8,640 Results

Phase III RANGE trial of Cyramza shows positive trend in advanced urothelial carcinoma.- Eli Lilly.

 Added 18 hours ago

Eli Lilly announced additional results from its global, randomized, double-blind, placebo-controlled Phase III RANGE trial evaluating Cyramza (ramucirumab) in combination...

Higher cleansing scores correlate with increased polyp detection in patients with potential colorectal cancer- Norgine B.V.

 Added 1 day ago

Norgine B.V. announced new data showing that there is a strong correlation between higher cleansing scores and increased polyp detection...

Takeda makes fourth proposal for takeover of Shire plc

 Added 1 day ago

Shire notes the announcement made by Takeda and confirms it has received a fourth proposal on 20 April 2018 regarding...

Basilea licenses ARQ 087 from ArQule Inc for non Chinese markets as a treatment for biliary cancer.

 Added 1 day ago

Basilea Pharmaceutica Ltd. announced that it has entered into a license agreement with ArQule, Inc. for its oncology drug candidate...

FDA approves BRUKER MALDI Biotyper CA system for the identification of C. auris which can cause serious infections in hospitalized patients.-Bruker Daltonik GmbH.

 Added 1 day ago

The FDA has authorized the first test to identify the emerging pathogen Candida auris (C. auris), which can cause serious...

FDA 510(k) approval for ADVANTAGE PLUS Pass-Thru automated endoscope reprocessor for infection prevention.-Cantel Corpn.

 Added 2 days ago

Cantel Medical Corp.announced that it has received FDA 510 (k) clearance for its ADVANTAGE PLUS Pass-Thru automated endoscope reprocessor (AER)....

FDA advisory committee recommends approval of Epidiolex for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome .- GW Pharma.

 Added 2 days ago

GW Pharmaceuticals plc along with its U.S. subsidiary Greenwich Biosciences, announced that the Peripheral and Central Nervous System Drugs Advisory...

CE Mark for Vagus Nerve Stimulation Therapy System.- LivaNova

 Added 2 days ago

LivaNova PLC announced it received CE Mark for its Vagus Nerve Stimulation Therapy System comprised of the SenTiva generator and...

FDA approves fixed dose Akynzeo IV for chemotherapy induced nausea and vomiting.- Helsinn.

 Added 2 days ago

Helsinn announces that the FDA has approved the intravenous formulation of Akynzeo (NEPA), a fixed antiemetic combination of fosnetupitant, 235mg,...

FDA approves PartoSure diagnostic to assess risk of spontaneous preterm birth.- Qiagen.

 Added 2 days ago

Qiagen announced the U.S. regulatory approval of PartoSure, which is a novel test for assessing the risk of spontaneous preterm...

Load more